(Q35048843)
Statements
Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells (English)
Matthew C Catley
Joanna E Chivers
1 reference
1 reference
1 reference